Abstract This 2022 European Atherosclerosis Society lipoprotein (a)[Lp (a)] consensus
statement updates evidence for the role of Lp (a) in atherosclerotic cardiovascular disease …

Lipoprotein (a)(Lp (a)) is a complex circulating lipoprotein, and increasing evidence has
demonstrated its role as a risk factor for atherosclerotic cardiovascular disease (ASCVD) …

Aims Familial hypercholesterolaemia (FH) predisposes children to the early initiation of
atherosclerosis and is preferably diagnosed by DNA analysis. Yet, in many children with a …

Aims In view of the consolidating evidence on the causal role of Lp (a) in cardiovascular
disease, the Italian Society for the Study of Atherosclerosis (SISA) has assembled a …

Familial hypercholesterolemia (FH) is the most frequent genetic disorder resulting in
increased low-density lipoprotein cholesterol (LDL-C) levels from childhood, leading to …

Elevated lipoprotein (a)[Lp (a)], a predominantly genetic disorder, is a causal risk factor for
atherosclerotic cardiovascular disease (ASCVD) and calcific aortic valvular disease …

Abstract Purpose of Review Familial hypercholesterolemia is a high cardiovascular risk
disorder. We will review the role of lipoprotein (a) in cardiovascular risk and in aortic valve …

Abstract Objective Elevated lipoprotein (a)[Lp (a)] is a common inherited condition
associated with cardiovascular disease. This study investigated whether cascade testing for …

Elevated lipoprotein (a) is a genetically transmitted codominant trait that is an independent
risk driver for cardiovascular disease. Lipoprotein (a) concentration is heavily influenced by …

The evaluation of serum Lp (a) values in childhood and adolescence has been widely
debated, and in the last few years, many authors have tried to better define Lp (a) role in …